[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-342777-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-342777-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","human-circular-rna-hsa_circ_0000231-clinical-diagnostic-effectiveness-as-a-new-tumor-marker-in-gastric-cancer","Human circular RNA hsa_circ_0000231 clinical diagnostic effectiveness as a new tumor marker in gastric cancer","","Gastric cancer often presents with subtle early symptoms, leading to late-stage diagnosis and a need for reliable, non-invasive diagnostic markers with high sensitivity and specificity. This study identifies hsa_circ_0000231 as a serum biomarker and evaluates its clinical diagnostic value. Agarose gel electrophoresis, RNase R, and Sanger sequencing confirm stability and structure, while qRT-PCR and ROC analysis assess expression patterns and diagnostic performance.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/human-circular-rna-hsa_circ_0000231-clinical-diagnostic-effectiveness-as-a-new-tumor-marker-in-gastric-cancer/342777/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/human-circular-rna-hsa_circ_0000231-clinical-diagnostic-effectiveness-as-a-new-tumor-marker-in-gastric-cancer/342777.png","ImageObject",300,407,{"name":42,"@type":43},"Aurora","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why are new diagnostic markers needed for gastric cancer?","Question",{"text":63,"@type":64},"Most patients are diagnosed at later stages because early symptoms are subtle. Existing markers lack sufficient sensitivity and specificity, so improved diagnostic performance is required.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was hsa_circ_0000231 validated in this study?",{"text":68,"@type":64},"Stability and correct structure were assessed using agarose gel electrophoresis, RNase R assay, and Sanger sequencing.",{"name":70,"@type":61,"acceptedAnswer":71},"What diagnostic performance did hsa_circ_0000231 show?",{"text":72,"@type":64},"hsa_circ_0000231 had an ROC AUC of 0.781, outperforming markers including CEA, CA19-9, and CA72-4. Combining four indicators increased diagnostic accuracy with an AUC of 0.833.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},342777,1790510468,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":123,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":33,"preview_urls":145},4810365810221,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","DOI: 10.1002/cnr2.2081  \nO R IG INA L ARTI CLE  \nHuman circular RNA hsa_circ_ 0000231 clinical diagnostic effectiveness as a new tumor marker in gastric cancer  \nRonghua Fang 1,2  | Wentao Yuan 1,2 | Chunyan Mao 1,2 | Jing Cao 3 | Hongmei Chen 4 | Xiuying Shi 1 | Hui Cong 1,3  \n1Department of Laboratory Medicine, Affiliated Hospital of Nantong University, Nantong, China  \n2Department of Clinical Medicine, Medical School of Nantong University, Nantong, China 3Department of Blood Transfusion, Affiliated Hospital of Nantong University, Nantong, China  \n4Vip Ward, Affiliated Hospital of Nantong University, Nantong, China  \nCorrespondence  \nXiuying Shi and Hui Cong, Departments of Laboratory Medicine, Affiliated Hospital of Nantong University, \\#20 Xisi Road, Nantong 226001, China.  \nEmail: [shixiuying@ntu.edu.cn](shixiuying@ntu.edu.cn) and huicjs@  \n[163.com](163.com)  \nFunding information  \nJiangsu Provincial Health Commission, Grant/Award Number: ZD2022008; Nantong Technology Project, Grant/Award Numbers: MS12017008-1, MS12020007, JCZ20009  \nAbstract  \nBackground: Owing to the subtlety of initial symptoms associated with gastric cancer (GC), the majority of patients are diagnosed at later stages. Given the absence of reliable diagnostic markers, it is imperative to identify novel markers that exhibit high sensitivity and specificity. Circular RNA, a non-coding RNA, plays an important role in tumorigenesis and development and is well expressed in body fluids.  \nAims: In this study, we aimed to identify hsa_circ_ 0000231 as a new biomarker for the diagnosis of GC and to assess its clinical diagnostic value in serum.  \nMethods and Results: The stability and correctness of hsa_circ_ 0000231 was determined by agarose gel electrophoresis, Rnase R assay and Sanger sequencing. Realtime quantitative polymerase chain reaction (qRT-PCR) was designed to discover the expression level of hsa_circ_0000231 and whether it has dynamic serum monitoring capability. The correlation between hsa_circ_ 0000231 and clinicopathological parameters was analyzed by collecting clinical and pathological data from GC patients. In addition, diagnostic efficacy was assessed by constructing receiver operating characteristic curves (ROC) . Hsa_circ_ 0000231 exhibits a stable and consistently expressed structure. In GC serum, cells, and tissues, it demonstrates reduced expression levels. Elevated expression levels observed postoperatively suggest its potential for dynamic monitoring. Additionally its expression level correlates with TNM staging and neuro/ vascular differentiation. The area under ROC curve (AUC) for hsa_circ_ 0000231 is 0.781, indicating its superior diagnostic value compared to CEA, CA19-9, and CA72-4 . The combination of these four indicators enhances diagnostic accuracy, with an AUC of 0 .833.  \nConclusions: The stable expression of hsa_circ_ 0000231 in the serum of gastric cancer patients holds promise as a novel biomarker for both the diagnosis and dynamic monitoring of GC.  \nKEYWOR DS  \nbiomarkers, circular RNA, diagnostic, gastric cancer, hsa_circ_0000231  \nThis is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.  \n© 2024 The Authors. Cancer Reports published by Wiley Periodicals LLC.  \nCancer Reports. 2024;7:e2081 .  \n[https://doi.org/10.1002/cnr2.2081](https://doi.org/10.1002/cnr2.2081)  \n[wileyonlinelibrary.com/journal/cnr2](wileyonlinelibrary.com/journal/cnr2)  \n1 of 10  \n1 | INTRODUCTION  \nGastric cancer (GC) is one of the most common malignant tumors in the world. The latest statistics need to show that the incidence and mortality of gastric cancer rank fifth (5.6%) and third (7.7%) in the world.1 GC is typically discovered at an advanced stage with malignant hyperplasia and lymph node metastases due to the lack of early signs.2 Upper gastrointestinal endoscopy and pathology biopsy remain the g","cbCaib6PTcY1Mn1R","https://ap.wps.com/l/cbCaib6PTcY1Mn1R","pdf",23356407,"English","# Introduction\n## Gastric cancer and current diagnostic limitations\n## Circular RNA biology and biomarker potential\n# Methods and Results\n## Biomarker identification and stability assessment\n## Expression analysis in clinical samples\n## Diagnostic efficacy and ROC evaluation\n# Conclusions","[{\"question\":\"Why are new diagnostic markers needed for gastric cancer?\",\"answer\":\"Most patients are diagnosed at later stages because early symptoms are subtle. Existing markers lack sufficient sensitivity and specificity, so improved diagnostic performance is required.\"},{\"question\":\"How was hsa_circ_0000231 validated in this study?\",\"answer\":\"Stability and correct structure were assessed using agarose gel electrophoresis, RNase R assay, and Sanger sequencing.\"},{\"question\":\"What diagnostic performance did hsa_circ_0000231 show?\",\"answer\":\"hsa_circ_0000231 had an ROC AUC of 0.781, outperforming markers including CEA, CA19-9, and CA72-4. Combining four indicators increased diagnostic accuracy with an AUC of 0.833.\"}]","Human circular RNA hsa_circ_0000231 clinical diagnostic effectiveness as a new tumor marker in gastric cancer | PDF",1790048215,25,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0935ef138b8cca86ebcfc22c5f3c5106.webp",983,1291,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/43de47d74d15a66fc0884afa1547c59c.webp",982,1290,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/79ca38f132729fff451587edce85c71f.webp",981,1289,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0108ac7c6f1f036dbe0ffde78963b702.webp",980,1287]